Valuation: Dermapharm Holding SE

Market Cap 1.97B 2.27B 1.84B 1.68B 3.17B 217B 3.22B 21.62B 8.47B 108B 8.53B 8.35B 362B P/E 2026 *
15.8x
P/E 2027 * 13.6x
Enterprise Value 2.67B 3.08B 2.49B 2.28B 4.28B 293B 4.36B 29.25B 11.46B 147B 11.55B 11.3B 490B EV / Sales 2026 *
2.21x
EV / Sales 2027 * 2.08x
Free-Float
10.7%
Yield 2026 *
2.46%
Yield 2027 * 2.83%
1 day+1.13%
1 week-2.31%
Current month-1.95%
1 month-9.87%
3 months-13.17%
6 months+8.94%
Current year+2.16%
1 week 39.7
Extreme 39.7
41.55
1 month 39.7
Extreme 39.7
45.75
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2017
Director of Finance/CFO - 01/11/2022
Investor Relations Contact - 01/12/2018
Director TitleAgeSince
Chairman 70 01/08/2017
Director/Board Member 66 01/08/2017
Director/Board Member 77 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
07/01/26 Buy 150 0.0003%
07/01/26 Buy 150 0.0003%
07/01/26 Buy 2,050 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%-2.31%+24.07%-6.07% 2.27B
-0.62%+2.42%+87.38%+122.71% 1,083B
-0.79%-0.57%+48.23%+47.67% 626B
-0.66%-0.21%+23.69%+61.35% 442B
-1.72%-0.85%+46.75%+36.53% 363B
-1.62%-1.14%+27.86%+35.33% 295B
-1.22%-3.44%+4.83%+4.57% 248B
-0.40%+0.68%+44.08%+57.33% 224B
-2.93%+0.71%-7.52%-52.14% 210B
-0.14%+1.18%+11.08%+66.96% 168B
Average -0.84%+2.19%+31.05%+37.42% 366.14B
Weighted average by Cap. -0.93%+4.28%+46.95%+62.23%

Financials

2026 *2027 *
Net sales 1.21B 1.39B 1.13B 1.03B 1.94B 133B 1.98B 13.27B 5.2B 66.58B 5.24B 5.12B 222B 1.25B 1.45B 1.17B 1.07B 2.02B 138B 2.05B 13.77B 5.4B 69.11B 5.44B 5.32B 231B
Net income 135M 156M 126M 115M 217M 14.86B 221M 1.48B 581M 7.44B 585M 572M 24.81B 155M 179M 145M 133M 249M 17.08B 254M 1.7B 667M 8.55B 672M 658M 28.52B
Net Debt 696M 803M 651M 594M 1.12B 76.58B 1.14B 7.64B 2.99B 38.33B 3.01B 2.95B 128B 636M 733M 595M 543M 1.02B 69.95B 1.04B 6.98B 2.73B 35.01B 2.75B 2.69B 117B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,503
Date Price Change Volume
12/08/26 40.20 +1.13% 12,441
11/08/26 €39.75 -1.85% 29,609
10/08/26 €40.50 0.00% 31,311
07/08/26 €40.50 -0.86% 10,261
06/08/26 €40.85 -0.73% 6,702
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
39.75EUR
Average target price
50.38EUR
Spread / Average Target
+26.73%

Quarterly revenue - Rate of surprise